Global gene expression changes in the prefrontal cortex of rabbits with hypercholesterolemia and/or hypertension

[1]  S. Akabane,et al.  Alterations in renal Na+K+ATPase activity and [3H]ouabain binding in Goldblatt hypertensive rabbits. , 1985, Journal of hypertension.

[2]  S. Little,et al.  Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.

[3]  W. Strittmatter,et al.  Transthyretin sequesters amyloid beta protein and prevents amyloid formation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[5]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[6]  Laurent Duret,et al.  Phylogenetic position of the order Lagomorpha (rabbits, hares and allies) , 1996, Nature.

[7]  I. Herr,et al.  The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.

[8]  M. Emmerling,et al.  Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. , 1998, Biochemical and biophysical research communications.

[9]  S. Doggrell,et al.  Rat models of hypertension, cardiac hypertrophy and failure. , 1998, Cardiovascular research.

[10]  B. Greenberg,et al.  Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol* , 1998, The Journal of Biological Chemistry.

[11]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[12]  J. Pasquini,et al.  Defective ubiquitination of cerebral proteins in Alzheimer's disease , 2000, Journal of neuroscience research.

[13]  D. Sparks,et al.  Alterations of Alzheimer's Disease in the Cholesterol‐fed Rabbit, Including Vascular Inflammation: Preliminary Observations , 2000, Annals of the New York Academy of Sciences.

[14]  Pascale Barberger-Gateau,et al.  Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study , 2000, Neuroepidemiology.

[15]  G. Siest,et al.  Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[16]  M. Mercken,et al.  A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease , 2001, Neurobiology of Disease.

[17]  T. Taira,et al.  MM-1, a c-Myc-binding Protein, Is a Candidate for a Tumor Suppressor in Leukemia/Lymphoma and Tongue Cancer* , 2001, The Journal of Biological Chemistry.

[18]  V. Haroutunian,et al.  Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.

[19]  D. Braguer,et al.  Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug‐induced apoptosis in neuroblastoma cells , 2001, Journal of neuroscience research.

[20]  K. Sugamura,et al.  A Novel Serum Protein That Is Selectively Produced by Cytotoxic Lymphocytes1 , 2001, The Journal of Immunology.

[21]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[22]  T. Russo,et al.  Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain* , 2002, The Journal of Biological Chemistry.

[23]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[24]  P. Macfarlane,et al.  Association between high‐density lipoprotein and cognitive impairment in the oldest old , 2002, Annals of neurology.

[25]  D. Sparks,et al.  Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Mu-jun Zhao,et al.  Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. , 2003, The Biochemical journal.

[27]  K. Fukuchi,et al.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. , 2003, The American journal of pathology.

[28]  L. Thal,et al.  Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology , 2003, Neurology.

[29]  D. Molfese,et al.  Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.

[30]  Eva Czirr,et al.  Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules , 2004, Journal of Cell Science.

[31]  A. Yanni,et al.  The laboratory rabbit: an animal model of atherosclerosis research , 2004, Laboratory animals.

[32]  IngemarBjörkhem,et al.  Brain Cholesterol: Long Secret Life Behind a Barrier , 2004 .

[33]  Steven J. Schrodi,et al.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Steve Meaney,et al.  Crossing the barrier: Published, JLR Papers in Press, March 1, 2005. DOI 10.1194/jlr.M500024-JLR200 net flux of 27-hydroxycholesterol into the human brain , 2005, Journal of Lipid Research.

[35]  J. Sweatt,et al.  ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. , 2006, Learning & memory.

[36]  M. Schrag,et al.  Deposition of iron and β‐amyloid plaques is associated with cortical cellular damage in rabbits fed with long‐term cholesterol‐enriched diets , 2006, Journal of neurochemistry.

[37]  S. Proctor,et al.  Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[38]  M. Sastre,et al.  Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease , 2006, Progress in Neurobiology.

[39]  R. Murphy,et al.  Kinetics of inhibition of beta-amyloid aggregation by transthyretin. , 2006, Biochemistry.

[40]  R. Murphy,et al.  Kinetics of inhibition of β-amyloid aggregation by transthyretin , 2006 .

[41]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[42]  Aimin Zhou,et al.  RNase L: Its biological roles and regulation , 2006, IUBMB life.

[43]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[44]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[45]  A. Levitzki,et al.  Subunit S5a of the 26S proteasome is regulated by antiapoptotic signals , 2007, The FEBS journal.

[46]  Joseph L. Goldstein,et al.  Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig , 2007, Proceedings of the National Academy of Sciences.

[47]  R. Lehner,et al.  Attenuation of Adipocyte Triacylglycerol Hydrolase Activity Decreases Basal Fatty Acid Efflux* , 2007, Journal of Biological Chemistry.

[48]  E. Kua,et al.  Metabolic syndrome and cognitive decline in chinese older adults: results from the singapore longitudinal ageing studies. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[49]  A. Chawla,et al.  Cidea is associated with lipid droplets and insulin sensitivity in humans , 2008, Proceedings of the National Academy of Sciences.

[50]  P. Francis,et al.  Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors , 2008, Neurobiology of Aging.

[51]  Huaxi Xu,et al.  Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation , 2008, Molecular Neurodegeneration.

[52]  O. Ghribi.  Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle. , 2008, Journal of Alzheimer's disease : JAD.

[53]  P. Francis,et al.  Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. , 2008, Neurobiology of aging.

[54]  K. Chung,et al.  Down syndrome critical region 2 protein inhibits the transcriptional activity of peroxisome proliferator-activated receptor beta in HEK293 cells. , 2008, Biochemical and biophysical research communications.

[55]  J. Geiger,et al.  Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease , 2008, Journal of Neuroinflammation.

[56]  J. Zhang,et al.  Molecular cloning, chromosomal location and expression pattern of porcine CIDEa and CIDEc , 2009, Molecular Biology Reports.

[57]  A Hofman,et al.  Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[58]  F. Gonzalez,et al.  Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. , 2008, Cell metabolism.

[59]  A. Granholm,et al.  Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. , 2008, Journal of Alzheimer's disease : JAD.

[60]  F. Panza,et al.  Vascular risk factors, alcohol intake, and cognitive decline , 2008, The journal of nutrition, health & aging.

[61]  D. Inzitari,et al.  Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  Zhiqi Sun,et al.  CIDE proteins and metabolic disorders , 2009, Current opinion in lipidology.

[63]  D. Craig,et al.  A novel reciprocal and biphasic relationship between membrane cholesterol and β‐secretase activity in SH‐SY5Y cells and in human platelets , 2009, Journal of neurochemistry.

[64]  T. Wengenack,et al.  Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid β peptide capturing- and plaque binding-monoclonal antibodies , 2009, Alzheimer's & Dementia.

[65]  J. Buxbaum,et al.  Transthyretin: the servant of many masters , 2009, Cellular and Molecular Life Sciences.

[66]  G. Lembo,et al.  β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension , 2009, Neurobiology of Aging.

[67]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[68]  Andrew J. Brown,et al.  Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. , 2009, Molecular aspects of medicine.

[69]  Jing Ye,et al.  Identification of lipid droplet-associated proteins in the formation of macrophage-derived foam cells using microarrays. , 2010, International journal of molecular medicine.

[70]  Yong-Keun Jung,et al.  Amyloid β-induced FOXRED2 mediates neuronal cell death via inhibition of proteasome activity , 2011, Cellular and Molecular Life Sciences.

[71]  Lennart Opitz,et al.  Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.

[72]  C. Humpel,et al.  Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits , 2010, Molecular and Cellular Neuroscience.

[73]  A. Catto-Smith,et al.  Interaction of Crohn's Disease Susceptibility Genes in an Australian Paediatric Cohort , 2010, PloS one.

[74]  R. Mayeux,et al.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. , 2010, Archives of neurology.

[75]  K. Gautvik,et al.  POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas , 2010, PloS one.

[76]  A. Goate,et al.  Niemann-Pick type C cells show cholesterol dependent decrease of APP expression at the cell surface and its increased processing through the beta-secretase pathway. , 2010, Biochimica et biophysica acta.

[77]  J. Geiger,et al.  Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. , 2011, Journal of Alzheimer's disease : JAD.

[78]  O. Ghribi,et al.  Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. , 2010, Journal of Alzheimer's disease : JAD.

[79]  H. Inoko,et al.  Which CIDE are you on? Apoptosis and energy metabolism. , 2011, Molecular bioSystems.

[80]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[81]  Sudarshan C. Upadhya,et al.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. , 2011, Biochimica et biophysica acta.

[82]  J. Sweatt,et al.  Epigenetic Modifications in Neurons are Essential for Formation and Storage of Behavioral Memory , 2011, Neuropsychopharmacology.

[83]  G. Lembo,et al.  'Alzheimer-like' pathology in a murine model of arterial hypertension. , 2011, Biochemical Society transactions.

[84]  Weihong Song,et al.  Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model , 2011, Journal of visualized experiments : JoVE.

[85]  E. Morrison,et al.  The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer , 2010, Cholesterol.

[86]  Brij B. Singh,et al.  Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina , 2011, BMC ophthalmology.

[87]  B. Winblad,et al.  Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation , 2011, Journal of Lipid Research.

[88]  G. Gambina,et al.  Influence of Variation in the Follicle-Stimulating Hormone Receptor Gene (FSHR) and Age at Menopause on the Development of Alzheimer’s Disease in Women , 2011, Dementia and Geriatric Cognitive Disorders.

[89]  Ge Li,et al.  Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease , 2011, PloS one.

[90]  Anna Kinsey,et al.  Plasma transthyretin as a candidate marker for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[91]  P. Li,et al.  Cidea promotes hepatic steatosis by sensing dietary fatty acids , 2012, Hepatology.

[92]  Chul-Seung Park,et al.  Cereblon inhibits proteasome activity by binding to the 20S core proteasome subunit beta type 4. , 2012, Biochemical and biophysical research communications.

[93]  D. Sparks,et al.  Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[94]  Li Xu,et al.  CIDE Proteins and Lipid Metabolism , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[95]  S. Haggarty,et al.  An epigenetic blockade of cognitive functions in the neurodegenerating brain , 2012, Nature.

[96]  L. Launer,et al.  Midlife Blood Pressure, Plasma &bgr;-Amyloid, and the Risk for Alzheimer Disease: The Honolulu Asia Aging Study , 2012, Hypertension.

[97]  York Winter,et al.  Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline , 2012, Nature Medicine.

[98]  R. Silverman,et al.  RNase L Triggers Autophagy in Response to Viral Infections , 2012, Journal of Virology.

[99]  M. Maeda,et al.  Prefoldin Protects Neuronal Cells from Polyglutamine Toxicity by Preventing Aggregation Formation* , 2013, The Journal of Biological Chemistry.

[100]  Denise C. Park,et al.  Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. , 2013, JAMA neurology.

[101]  J. Burns,et al.  Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. , 2013, Journal of Alzheimer's disease : JAD.

[102]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[103]  A. Catto-Smith,et al.  Pseudomonas infection in children with early-onset Crohn's disease: an association with a mutation close to PSMG1. , 2013, Inflammatory bowel diseases.

[104]  P. Wong,et al.  Comprehensive Gene Expression Profiling Reveals Synergistic Functional Networks in Cerebral Vessels after Hypertension or Hypercholesterolemia , 2013, PloS one.

[105]  Ping Zhang,et al.  Lack of RNase L Attenuates Macrophage Functions , 2013, PloS one.

[106]  J. Pedraza-Chaverri,et al.  Cullin 3 as a novel target in diverse pathologies☆ , 2013, Redox biology.

[107]  F. Remião,et al.  Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways. , 2013, Angewandte Chemie.

[108]  M. Mojarrad,et al.  Identification of Novel Hypoxia Response Genes in Human Glioma Cell Line A172 , 2013, Iranian journal of basic medical sciences.

[109]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[110]  G. Logroscino,et al.  Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging , 2010, Alzheimer's & Dementia.

[111]  P. Adlard,et al.  Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease , 2014, Neurobiology of Aging.

[112]  A. Russell,et al.  Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes , 2013, Nature chemical biology.

[113]  Li Wang,et al.  Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease , 2014, PloS one.

[114]  N. Inestrosa,et al.  Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum , 2014, Progress in Neurobiology.

[115]  P. Moreira,et al.  Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia , 2014, Front. Endocrinol..

[116]  I. Mook‐Jung,et al.  Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation. , 2016, Journal of Alzheimer's disease : JAD.